These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32054078)

  • 1. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs role as potential biomarkers and key regulators in melanoma.
    Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C
    Genes Chromosomes Cancer; 2017 Jan; 56(1):3-10. PubMed ID: 27561079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNAs in primary cutaneous lymphomas.
    Yu X; Li Z; Liu J
    Cell Prolif; 2015 Jun; 48(3):271-7. PubMed ID: 25736784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on melanoma epigenetics.
    de Unamuno B; Palanca S; Botella R
    Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
    Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
    PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of microRNAs and their implications in uveal melanoma.
    Yang C; Wang Y; Hardy P
    Cell Mol Life Sci; 2021 Jan; 78(2):545-559. PubMed ID: 32783068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs in melanoma: a defined role in tumor progression and metastasis.
    Mannavola F; Tucci M; Felici C; Stucci S; Silvestris F
    Expert Rev Clin Immunol; 2016; 12(1):79-89. PubMed ID: 26505837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma.
    Nguyen MT; Luo YH; Li AL; Tsai JC; Wu KL; Chung PJ; Ma N
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab.
    Wagenseller AG; Shada A; D'Auria KM; Murphy C; Sun D; Molhoek KR; Papin JA; Dutta A; Slingluff CL
    J Transl Med; 2013 Sep; 11():218. PubMed ID: 24047116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.
    Dong L; Tian X; Zhao Y; Tu H; Wong A; Yang Y
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.